We are live on ! Find out more
BSX icon

Boston Scientific

698 hedge funds and large institutions have $49.2B invested in Boston Scientific in 2018 Q3 according to their latest regulatory filings, with 90 funds opening new positions, 235 increasing their positions, 239 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $232M | Put options by funds: $100M

61% more first-time investments, than exits

New positions opened: 90 | Existing positions closed: 56

20% more funds holding in top 10

Funds holding in top 10: 1518 (+3)

18% more capital invested

Capital invested by funds: $41.7B → $49.2B (+$7.52B)

4% more funds holding

Funds holding: 671698 (+27)

0.2% less ownership

Funds ownership: 92.63%92.42% (-0.2%)

2% less repeat investments, than reductions

Existing positions increased: 235 | Existing positions reduced: 239

Holders
698
Holders Change
+27
Holders Change %
+4.02%
% of All Funds
15.96%
Holding in Top 10
18
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+20%
% of All Funds
0.41%
New
90
Increased
235
Reduced
239
Closed
56
Calls
$232M
Puts
$100M
Net Calls
+$132M
Net Calls Change
+$33.9M
Name Holding Trade Value Shares
Change
Change in
Stake
FMI
701
Factory Mutual Insurance
Massachusetts
-$18M -550,000 Closed
QIM
702
Quantitative Investment Management
Virginia
-$12.8M -392,400 Closed
SCM
703
Sio Capital Management
New York
-$5.97M -182,633 Closed
AIM
704
Assured Investment Management
New York
-$5.3M -162,079 Closed
AIMCA
705
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$4.79M -146,500 Closed
ARTA
706
A.R.T. Advisors
New York
-$3.63M -110,900 Closed
CM
707
Crestline Management
Texas
-$3.46M -105,950 Closed
MFP
708
Michael F. Price
-$3.35M -102,500 Closed
DF
709
Donoghue Forlines
Massachusetts
-$2.19M -66,887 Closed
SCM
710
Stevens Capital Management
Pennsylvania
-$1.49M -45,672 Closed
Tudor Investment Corp
711
Tudor Investment Corp
Connecticut
-$1M -30,623 Closed
CA
712
Corrado Advisors
New Jersey
-$936K -28,635 Closed
TSS
713
Two Sigma Securities
New York
-$929K -26,592 Closed
SCC
714
Spring Creek Capital
Kansas
-$850K -25,994 Closed
JFG
715
Jefferies Financial Group
New York
-$817K -25,000 Closed
JIM
716
Jupiter Investment Management
United Kingdom
-$631K -19,300 Closed
Parallax Volatility Advisers
717
Parallax Volatility Advisers
California
-$641K -18,365 Closed
EIM
718
Essex Investment Management
Massachusetts
-$567K -17,352 Closed
TCM
719
Teza Capital Management
Illinois
-$491K -15,001 Closed
HM
720
Harvest Management
New York
-$370K -11,300 Closed
GCP
721
GSA Capital Partners
United Kingdom
-$354K -10,838 Closed
SEC
722
Seven Eight Capital
New York
-$343K -10,491 Closed
Susquehanna International Group
723
Susquehanna International Group
Pennsylvania
-$325K -9,308 Closed
DCM
724
Dynamic Capital Management
Jersey
-$303K -9,256 Closed
LOAMU
725
Lombard Odier Asset Management (USA)
New York
-$245K -7,500 Closed

BSX Hedge Fund Activity: Q3 2018 in Review

698 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q3 2018, worth a combined $49.2B — up 18% from $41.7B a quarter earlier.

Buyers outnumbered sellers: 90 funds opened new BSX positions and 56 closed out — a net gain of 34 holders — while 235 added to existing stakes and 239 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $308M. The largest seller was Capital World Investors, cutting an estimated $626M.

  • 698 institutional investors held Boston Scientific (BSX) as of Q3 2018, up from 671 in Q2 2018.
  • Funds reported $49.2B of Boston Scientific stock for Q3 2018, up 18% quarter-over-quarter.
  • 90 funds opened new Boston Scientific positions in Q3 2018 and 56 closed out, a net change of +34 holders.
  • The largest Boston Scientific buyer in Q3 2018 was Capital Research Global Investors, an estimated $308M added.
  • The largest Boston Scientific seller in Q3 2018 was Capital World Investors, an estimated $626M sold.

Based on aggregated 13F filings for Q3 2018.